8-K
filed May 26, 2026, 4:02 PM ET
ticker SPRB
CIK 0001683553
other material
confidence high
sentiment neutral
materiality 0.15
Spruce Biosciences annual meeting results: directors elected, say-on-pay passed, frequency set to every year
SPRUCE BIOSCIENCES, INC.
- Annual meeting held May 21, 2026; quorum of 65.86% (903,893 of 1,372,278 shares outstanding).
- Class III directors elected: Michael Grey (276,159 for), Camilla V. Simpson (191,284 for), Javier Szwarcberg (293,098 for).
- Ratification of BDO USA as auditor for FY 2026 approved: 880,984 for, 16,851 against.
- Advisory say-on-pay approved with 187,027 for, 111,274 against, 1,573 abstentions (62.7% approval on votes cast).
- Stockholders voted for annual advisory votes on executive compensation; company will hold annual say-on-pay until 2032.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
SPRUCE BIOSCIENCES, INC. shareholders approved Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation at the 2026-05-21 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2026-05-21
Exact text from the filing
Proposal 4: Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation. The Company’s stockholders indicated, on an advisory basis, their preference for the Company to hold a stockholder advisory vote on the compensation of the Company’s named executive officers every year.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
SPRUCE BIOSCIENCES, INC. shareholders approved Advisory Vote on the Compensation of the Company’s Named Executive Officers at the 2026-05-21 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2026-05-21
Exact text from the filing
Proposal 3: Advisory Vote on the Compensation of the Company’s Named Executive Officers. The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s definitive proxy statement filed with the Securities and Exchange Commission (the “SEC”) on April 9, 2026.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
SPRUCE BIOSCIENCES, INC. shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm at the 2026-05-21 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-21
Exact text from the filing
Proposal 2: Ratification of Selection of Independent Registered Public Accounting Firm. The Company’s stockholders ratified the selection by the Audit Committee of the Board of Directors of BDO USA, P.C. as the independent registered public accounting firm of the Company for the Company’s fiscal year ending December 31, 2026.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
SPRUCE BIOSCIENCES, INC. shareholders approved Election of Class III Directors at the 2026-05-21 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-21
Exact text from the filing
Proposal 1: Election of Class III Directors. The Company’s stockholders elected each of the three nominees named below to serve as Class III directors of the Company until the Company’s 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, or until his or her earlier death, resignation or removal.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.